Key result
Phenylbutazone significantly reduced proteoglycan loss at clinically relevant concentrations, while Depo-Medrol caused a dose-dependent suppression of proteoglycan synthesis.
Phenylbutazone and methylprednisolone acetate exhibit anticatabolic effects on equine articular cartilage explants, suggesting therapeutic potential beyond soft tissue anti-inflammatory effects.
No takes yet. Share an insight, caveat, or question.
Caution against clinical extrapolation in horses; leaves open in vivo validation of cartilage effects.
Jolly et al. (1995) studied Equine articular cartilage explants (n=12). Phenylbutazone and Depo-Medrol vs. Control explants (0 micrograms/mL) was evaluated on Chondrocyte viability, proteoglycan synthesis, and proteoglycan depletion. Phenylbutazone significantly reduced proteoglycan loss at clinically relevant concentrations, while Depo-Medrol caused a dose-dependent suppression of proteoglycan synthesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: